Cardiovascular disease is the single most important issue in women’s health, killing roughly 305,000 women in the United States in 2023 alone. That’s about 1 in every 5 female deaths. Globally, ischemic heart disease is the leading cause of death for both sexes, responsible for 13% of all deaths worldwide. Yet heart disease in women remains widely underrecognized, undertreated, and misunderstood, partly because it often looks different in women than it does in men. That core problem, a deadly condition hiding in plain sight, sits at the center of a broader landscape of health challenges unique to or disproportionately affecting women.
Why Heart Disease Is Often Missed in Women
Most people picture a heart attack as sudden, crushing chest pain. That’s the classic presentation, and it’s more common in men. Women having a heart attack are far more likely to experience what doctors call “atypical” symptoms: shortness of breath, nausea, vomiting, dizziness, sweating, back pain, fatigue, or palpitations. In one hospital study published in the Journal of Mid-Life Health, about 85% of female heart attack patients presented with these atypical symptoms, compared to 70% of men. When a woman walks into an emergency room with back pain and nausea, the possibility of a heart attack may not be the first thing anyone considers.
This pattern connects to a broader problem. A large study published in the Proceedings of the National Academy of Sciences found that women’s pain scores in emergency departments were 10% less likely to even be recorded by nurses compared to men’s. Female patients also spent an additional 30 minutes in the emergency department on average (about 4.9 hours versus 4.4 hours for men), even after accounting for differences in patient characteristics and severity. These gaps in recognition and response time can be the difference between catching a cardiac event early and missing it entirely.
Breast Cancer Remains a Major Threat
After heart disease, cancer is one of the leading health concerns for women, and breast cancer is the most common type. The rate of new cases is about 131 per 100,000 women per year. The good news is that survival rates have improved dramatically when the disease is caught early. For breast cancer that’s still confined to the breast (localized stage), the five-year survival rate is effectively 100%. When it has spread to nearby lymph nodes, that drops to about 87%. If the cancer has metastasized to distant parts of the body, the five-year survival rate falls to roughly 33%.
These numbers make a powerful case for routine screening. About 64% of breast cancers are caught at the localized stage, when the prognosis is best. Cervical cancer screening follows a similar logic. Current guidelines recommend Pap tests every three years for women aged 21 to 29, and for women 30 to 65, either a combination of Pap and HPV testing every five years or a Pap test alone every three years.
The U.S. Maternal Mortality Crisis
The United States has the highest maternal mortality rate among wealthy nations, and the numbers vary dramatically by race. In 2023, the overall rate was 18.6 deaths per 100,000 live births. For Black women, that rate was 50.3, roughly three and a half times the rate for white women (14.5) and nearly five times the rate for Hispanic women (12.4). Age plays a significant role too: women 40 and older face a rate of 59.8 deaths per 100,000 births, nearly five times the rate for women under 25.
Geography compounds the problem. An estimated 2.2 million women of reproductive age live in counties with no access to maternity care at all. These so-called maternity care deserts have a maternal mortality rate of about 32 per 100,000 births, compared to roughly 24 per 100,000 in counties with full access. That’s a 36% higher risk of dying simply based on where you live. The causes of these deaths range from severe bleeding and infection to heart-related complications and high blood pressure disorders, many of which are preventable with timely care.
Autoimmune Disease Disproportionately Affects Women
About 80% of people with autoimmune diseases are women. Conditions like rheumatoid arthritis, multiple sclerosis, and scleroderma all show heavily lopsided female-to-male ratios. A Stanford Medicine-led study identified a molecular reason: a key process involved in silencing one of women’s two X chromosomes can sometimes trigger the immune system to attack the body’s own tissues. This helps explain why women’s immune systems, while generally more robust against infections, are also more prone to turning on themselves.
Living with an autoimmune condition often means navigating years of vague, overlapping symptoms before getting a diagnosis. Fatigue, joint pain, and brain fog are common early signs, and they’re easily dismissed or attributed to stress. The average time from first symptoms to an autoimmune diagnosis can stretch across multiple doctors and several years, a delay that allows disease progression and tissue damage to accumulate.
Dementia and Alzheimer’s Hit Women Harder
Alzheimer’s disease and other forms of dementia ranked as the seventh leading cause of death globally in 2021, killing 1.8 million people. Women bear a strikingly disproportionate share: 68% of those deaths are female. Part of this is explained by the fact that women live longer on average, and age is the biggest risk factor for dementia. But longevity alone doesn’t account for the full gap. Hormonal changes after menopause, differences in brain structure, and the cumulative effects of cardiovascular risk factors all appear to play a role.
The Gender Pain Gap
Across nearly every area of women’s health, a common thread emerges: women’s symptoms are more likely to be minimized, recorded less thoroughly, or attributed to psychological causes. The PNAS study on emergency department care found that the bias wasn’t subtle. Female patients’ pain was formally recorded less often, and they waited longer for care, with results that held up even after researchers controlled for the type and severity of the medical issue.
This pattern shows up beyond emergency rooms. Women with endometriosis wait an average of seven to ten years for a diagnosis. Women experiencing heart attacks are less likely to receive the same aggressive interventions as men. The cumulative effect is that conditions which are already more complex in women, whether due to hormonal fluctuations, atypical symptom presentation, or biological differences, face an additional layer of delay before they’re taken seriously.
Understanding these patterns is what makes the answer to “the most important issue in women’s health” more nuanced than a single disease. Heart disease kills the most women. But the reason it kills so many, and the reason maternal mortality is so high, autoimmune diseases go undiagnosed for years, and pain is undertreated, often traces back to the same root: health systems that were built around male physiology and are still catching up to the reality that women’s bodies signal danger differently.